Qbtech | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Founded in Sweden in 2002, this organization specializes in technology solutions for Attention Deficit Hyperactivity Disorder (ADHD). It is recognized for developing the QbTest, the first FDA-cleared objective test that evaluates and monitors ADHD symptoms. The QbTest uses a computer-based task combined with motion capture to measure activity, attention, and impulsivity for patients aged 6 to 60. Its flexible design allows it to be administered both in-clinic and remotely, serving clinicians and patients globally.

With a focus on bringing objectivity and standardization to ADHD care, the company’s technology enhances diagnostic accuracy and treatment monitoring. Supported by over 40 independent studies, their solutions improve access to care and clinician confidence. Their global operations include offices in Stockholm, Houston, and London, and services in 13 countries. Their innovative work has received multiple awards, including the 2022 HSJ Partnership Award for Best Mental Health Partnership with the NHS.